fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

How hepatitis E tricks the immune system

Written by | 22 Aug 2022

Over three million people are infected with the hepatitis E virus every year. So far, no effective treatment is available. An international team has investigated which factors are… read more.

COVID-19 mRNA vaccines are safe in pregnancy, large study confirms

Written by | 14 Aug 2022

COVID-19 mRNA vaccines are safe to use in pregnancy and pregnant women experienced lower rates of health events post vaccination than similarly aged, non-pregnant vaccinated people, suggests a… read more.

A new technology offers treatment for HIV infection through a single injection

Written by | 20 Jun 2022

A new study from Tel Aviv University offers a new and unique treatment for AIDS which may be developed into a vaccine or a one time treatment for… read more.

Why COVID vaccines are deemed non-essential for UK young children

Written by | 31 May 2022

Throughout the pandemic the University of Huddersfield’s Department of Pharmacy has been raising awareness on what vaccines are, how they are formulated, and why they’re an important part of… read more.

Study reports first use of antivirals in monkeypox patients, highlighting challenges in understanding and treating this rare disease

Written by | 30 May 2022

Peer-reviewed/ Case study/ People An analysis of seven cases of monkeypox that occurred in the UK between 2018-2021 reports on the first instances of in-hospital transmission and household… read more.

Herpesvirus infection may increase the risk of developing diabetes

Written by | 17 May 2022

A new study published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]) finds that two common herpesviruses may contribute to impaired glucose metabolism and… read more.

EU experts cautious on fourth dose of COVID-19

Written by | 30 Apr 2022

It is ‘too early’ to consider using a fourth dose of mRNA COVID-19 vaccines in the general population, according to the European Medicines Agency (EMA) and the European… read more.

UCLA’s HIV prevention and treatment center receives $7.5 million grant from NIH

Written by | 21 Mar 2022

The National Institute of Mental Health has renewed its support for UCLA’s collaborative Center for HIV Identification, Prevention and Treatment Services, or CHIPTS, with a five-year, $7.5 million grant. The… read more.

Suspending syringe services programs will result in an increase of HIV infections

Written by | 5 Mar 2022

Syringe services programs — sites where people who use drugs can access sterile syringes and dispose of injection equipment — often face political backlash. But a new study… read more.

Patient possibly cured of HIV infection by special stem-cell transplant

Written by | 23 Feb 2022

A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping… read more.

Phase III CARISEL study of Vocabria + Rekambys shows long-acting regimen is achievable in HIV – ViiV Healthcare

Written by | 9 Feb 2022

ViiV Healthcare presented positive interim data from the Phase III CARISEL study of Vocabria + Rekambys (cabotegravir + rilpivirine), which was initiated and conducted during the COVID-19 pandemic…. read more.

Are hedgehogs to blame for superbugs?

Written by | 10 Jan 2022

The threat of antimicrobial resistance (AMR), whereby antibiotics not longer work well on bacterial illness, is a slow-burning pandemic with the potential to eclipse even the worst of… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.